| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |